The recent reform to the industrial property code allows for "dual patenting" in Italy, meaning that an Italian national patent and a European patent can coexist on the same invention. This change has significant implications for pharmaceutical and biotechnology companies and provides them with additional options for patent protection. The reform also allows inventors to choose whether to enforce their European patent before the Unified Patent Court or their Italian patent before national courts. This "dual patenting" possibility is particularly important for industries where patent protection is crucial, such as the pharmaceutical sector.
Tags:
Notizie Brevi